Vanda Pharmaceuticals VNDA

$ 4.77 3.02%

Quarterly report 2024-Q3
added 11-07-2024

Vanda Pharmaceuticals Balance Sheet 2011-2024 | VNDA

Annual Balance Sheet Vanda Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-126 M	-124 M	-40.2 M	-48 M	-30.5 M	-61 M	-33.6 M	-40.4 M	-50.8 M	-60.9 M	-64.8 M	-88.8 M	-87.9 M
Long Term Debt	7.01 M	8.81 M	10.1 M	11.5 M	-	-	-	-	-	-	-	-	-
Long Term Debt Current	2.4 M	2.33 M	2.31 M	2.12 M	2.15 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	13.3 M	3.69 M	3.68 M	28.7 M	28.7 M	3.1 M	66.4 M	93.3 M	118 M
Total Current Liabilities	87.7 M	91.4 M	74.4 M	65.9 M	59.5 M	53 M	70.4 M	50.3 M	51.3 M	7.79 M	32.9 M	32.3 M	31.6 M
Total Liabilities	104 M	107 M	88.9 M	80.2 M	72.8 M	56.7 M	74 M	79 M	80 M	10.9 M	99.2 M	126 M	149 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	174 K	26.8 M	26.8 M	27.2 M
Retained Earnings	-155 M	-158 M	-164 M	-	-221 M	-336 M	-361 M	-346 M	-328 M	-288 M	-311 M	-291 M	-263 M
Total Assets	648 M	634 M	594 M	533 M	484 M	332 M	205 M	210 M	213 M	172 M	143 M	135 M	183 M
Cash and Cash Equivalents	136 M	135 M	52.6 M	61.6 M	45.1 M	61 M	33.6 M	40.4 M	50.8 M	60.9 M	64.8 M	88.8 M	87.9 M
Book Value	545 M	527 M	505 M	453 M	411 M	275 M	131 M	131 M	133 M	161 M	44.1 M	9.9 M	33.5 M
Total Shareholders Equity	545 M	527 M	505 M	453 M	411 M	275 M	131 M	131 M	133 M	161 M	44.1 M	9.9 M	33.5 M

All numbers in USD currency

Quarterly Balance Sheet Vanda Pharmaceuticals

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	5.49 M	6 M	7.01 M	7.47 M	7.94 M	8.39 M	8.81 M	8.9 M	-	9.66 M	10.1 M	10.5 M	10.7 M	11.1 M	11.5 M	11.5 M	11.5 M	11.5 M	12.5 M	12.5 M	12.5 M	12.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	104 M	109 M	104 M	98.5 M	102 M	109 M	107 M	106 M	-	101 M	88.9 M	86.4 M	86.4 M	75.6 M	80.2 M	80.2 M	80.2 M	80.2 M	72.8 M	72.8 M	72.8 M	72.8 M	56.7 M	56.7 M	56.7 M	56.7 M	74 M	74 M	74 M	74 M	79 M	79 M	79 M	79 M	80 M	80 M	80 M	80 M	10.9 M	10.9 M	10.9 M	10.9 M	99.2 M	99.2 M	99.2 M	99.2 M	126 M	126 M	126 M	126 M	149 M	149 M	149 M	149 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	174 K	31.2 M	31.1 M	31.1 M	26.8 M	26.8 M	26.8 M	26.8 M	26.8 M	26.8 M	26.8 M	26.8 M	26.8 M	26.8 M	26.8 M	26.8 M
Retained Earnings	-169 M	-164 M	-155 M	-153 M	-153 M	-155 M	-158 M	-165 M	-	-171 M	-164 M	-171 M	-179 M	-189 M	-197 M	-197 M	-197 M	-197 M	-221 M	-221 M	-221 M	-221 M	-336 M	-336 M	-336 M	-336 M	-361 M	-361 M	-361 M	-361 M	-346 M	-346 M	-346 M	-346 M	-328 M	-328 M	-328 M	-328 M	-288 M	-288 M	-288 M	-288 M	-308 M	-308 M	-308 M	-308 M	-291 M	-291 M	-291 M	-291 M	-263 M	-263 M	-263 M	-263 M
Total Assets	645 M	651 M	648 M	642 M	642 M	645 M	634 M	622 M	-	604 M	594 M	580 M	568 M	543 M	533 M	533 M	533 M	533 M	484 M	484 M	484 M	484 M	332 M	332 M	332 M	332 M	205 M	205 M	205 M	205 M	210 M	210 M	210 M	210 M	213 M	213 M	213 M	213 M	172 M	172 M	172 M	172 M	143 M	143 M	143 M	143 M	135 M	135 M	135 M	135 M	183 M	183 M	183 M	183 M
Cash and Cash Equivalents	100 M	103 M	136 M	183 M	150 M	354 M	135 M	49.4 M	58.2 M	66.9 M	52.1 M	50.5 M	57.2 M	72.1 M	61 M	61 M	61 M	61 M	45.1 M	45.1 M	45.1 M	45.1 M	61 M	61 M	61 M	61 M	33.6 M	33.6 M	33.6 M	33.6 M	40.4 M	40.4 M	40.4 M	40.4 M	50.8 M	50.8 M	50.8 M	50.8 M	60.9 M	60.9 M	60.9 M	60.9 M	64.8 M	64.8 M	64.8 M	64.8 M	88.8 M	88.8 M	88.8 M	88.8 M	87.9 M	87.9 M	87.9 M	87.9 M
Book Value	541 M	543 M	545 M	543 M	540 M	536 M	527 M	516 M	-	502 M	505 M	493 M	481 M	468 M	453 M	453 M	453 M	453 M	411 M	411 M	411 M	411 M	275 M	275 M	275 M	275 M	131 M	131 M	131 M	131 M	131 M	131 M	131 M	131 M	133 M	133 M	133 M	133 M	161 M	161 M	161 M	161 M	44.1 M	44.1 M	44.1 M	44.1 M	9.9 M	9.9 M	9.9 M	9.9 M	33.5 M	33.5 M	33.5 M	33.5 M
Total Shareholders Equity	541 M	543 M	545 M	543 M	540 M	536 M	527 M	516 M	509 M	502 M	505 M	493 M	481 M	468 M	453 M	453 M	453 M	453 M	411 M	411 M	411 M	411 M	275 M	275 M	275 M	275 M	131 M	131 M	131 M	131 M	131 M	131 M	131 M	131 M	133 M	133 M	133 M	133 M	161 M	161 M	161 M	161 M	44.1 M	44.1 M	44.1 M	44.1 M	9.9 M	9.9 M	9.9 M	9.9 M	33.5 M	33.5 M	33.5 M	33.5 M

All numbers in USD currency